Literature DB >> 26195267

Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysis.

Hai-Wei Miao1, Hui Gong2.   

Abstract

OBJECTIVE: Previous case-control studies on the relationship between the angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphisms and coronary restenosis did not reach the same conclusion. In the present study, we aimed to further evaluate the relationship between the ACE gene I/D polymorphisms and coronary restenosis, after percutaneous coronary intervention (PCI).
METHODS: By searching PubMed, EMBase, the Chinese Biomedical Literature Database and Wanfang database, we selected 16 case-control studies related to ACE gene I/D polymorphism and coronary restenosis after PCI. To test for heterogeneity in each study, we utilized the Q-test and I(2) test. To merge the odds ratio (OR) and 95% CI, we utilized the random effects model during the analyses.
RESULTS: The present study included 4693 subjects: 1241 patients with coronary restenosis and 3452 without coronary restenosis. By meta-analysis, we found there was significant association of ACE gene I/D polymorphism with coronary restenosis (D allele versus I allele: OR = 1.92; 95% CI (1.40-2.43); p < 0.001). A subgroup analysis, by stratification according to ethnicity, also showed that this association was found not only in the Caucasian population ((D allele versus I allele: OR = 1.94; 95% CI (1.38-2.80); p < 0.001)), but also in the Asian population ((D allele versus I allele: OR = 1.83; 95% CI (1.05-3.20); p = 0.03)). After stratification according to age, we found that the D allele carriers have a higher risk for development of coronary restenosis in subjects < 60 years old (OR = 2.13; 95% CI: 1.40-3.24; p = 0.0004); while in the subjects ⩾ 60 years old, the association was present with bordering significance (OR = 1.48; 95%CI: 0.98-2.25; p = 0.06).
CONCLUSIONS: The present study suggested that the ACE gene I/D polymorphism was associated with coronary restenosis, regardless of age and ethnicity.
© The Author(s) 2015.

Entities:  

Keywords:  Angiotensin-converting enzyme; coronary artery disease; coronary restenosis; gene polymorphism; meta-analysis; percutaneous coronary intervention; restenosis

Mesh:

Substances:

Year:  2015        PMID: 26195267     DOI: 10.1177/1470320315588233

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  4 in total

1.  Association of seven renin angiotensin system gene polymorphisms with restenosis in patients following coronary stenting.

Authors:  Min Zhu; Minjun Yang; Jiangbo Lin; Huanhuan Zhu; Yifei Lu; Bing Wang; Yinshen Xue; Congfeng Fang; Lijiang Tang; Baohui Xu; Jianjun Jiang; Xiaofeng Chen
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017-01       Impact factor: 1.636

2.  Angiotensin-Converting Enzyme Gene Deletion Polymorphism is Associated with Lymph Node Metastasis in Colorectal Cancer Patients in a Chinese Population.

Authors:  Xiao Zheng; Guoli Liu; Gang Cui; Ming Cheng; Nan Zhang; Sanyuan Hu
Journal:  Med Sci Monit       Date:  2017-10-15

3.  Predictive value of miRNA-21 on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.

Authors:  Haiyue Dai; Jun Wang; Zhongping Shi; Xiaojun Ji; Yiwei Huang; Rui Zhou
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

4.  Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease.

Authors:  Madina Azova; Kalima Timizheva; Amira Ait Aissa; Mikhail Blagonravov; Olga Gigani; Anna Aghajanyan; Leyla Tskhovrebova
Journal:  Biomolecules       Date:  2021-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.